Pasteur Act Reintroduced in Congress
Drug Topics
MAY 1, 2023
Both Democrats and Republicans voted to bring back the act that attempts to improve use of antibiotics
Mon.May 01, 2023
469 
New PhRMA Ad Campaign Sheds Light on PBM Abuses
PhRMA
MAY 1, 2023
The Pharmaceutical Research and Manufacturers of America (PhRMA) today launched a new ad campaign that continues to shed light on the role of pharmacy benefit managers (PBMs) in driving up health care costs and denying coverage of lifesaving medicines.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Pharmacists Find Marketing Success With Instagram, TikTok
Drug Topics
MAY 1, 2023
Pharmacists can reach the members of their community through creative use of social media platforms such as Instagram and TikTok.
A CEO’s quest to solve a 400-year-old medical mystery — and he’s also a patient
PharmaVoice
MAY 1, 2023
The CEO of Ventoux Biosciences has the disease that his company is aiming to treat, and it's driving him to find better medications.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
How Each COVID-19 Variant Impacts Children Differently
Drug Topics
MAY 1, 2023
Though the Omicron variant caused the most symptoms in pediatric patients, there were no differences in adverse outcomes by COVID-19 variant.
Americans want state policymakers to lower out-of-pocket costs
PhRMA
MAY 1, 2023
Too many Americans are struggling to access and afford their health care. While policy debates about how to address these issues can seem never ending, American adults largely agree on what state policymakers should be doing to help deliver relief to patients at the pharmacy counter.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Boxed Warnings Should Not Inhibit Use of All JAK Inhibitors for AD
Drug Topics
MAY 1, 2023
Brett King, MD, PhD, gave an in-depth overview of how JAK inhibitors earned a boxed warning and what it means for treating patients with atopic dermatitis at RAD 2023.
Novavax’s COVID-19 Vaccine Demonstrates Efficacious, Safe Response in Adolescents
Pharmacy Times
MAY 1, 2023
Analysis shows that the ratio of neutralizing antibody geometric mean titers in adolescents compared with young adults was 1.5 after vaccination with NVX-CoV2373.
Chatbots outperformed doctors in answering patient questions with accuracy and empathy: JAMA study
Fierce Healthcare
MAY 1, 2023
Chatbots outperformed doctors in answering patient questions with accuracy and empathy: JAMA study aburky Mon, 05/01/2023 - 13:58
New Therapeutics, Gene Therapies Show Promise in Rett Syndrome
Pharmacy Times
MAY 1, 2023
Session at the 2023 Asembia Summit notes that pharmacists play a particularly important role in the large multidisciplinary care team needed for Rett syndrome management.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: Sam Waksal and Jeremy Levin plot ‘the turnaround story of the century’
STAT
MAY 1, 2023
Over glasses of Chablis at Fleming by Le Bilboquet in Manhattan, two longtime friends and biotech lifers hashed out the deal that will bring their wending and colorful careers back together after three decades. Jeremy Levin, the professorial executive who has become one of the industry’s loudest voices on matters of social justice, is getting back into business with Sam Waksal, a hit-making drug developer with a gift for eloquence and a biography that doubles as biotech’s great unp
Pharmacists, Nurses Improve Medication Communication, Patient Experience Through Development or Medication Safety Patient Education Program
Pharmacy Times
MAY 1, 2023
Given the increasing value of patient satisfaction in determining the quality of care in the hospital reimbursement model, research is flourishing with a focus on identifying the factors that could positively influence patient satisfaction outcomes.
STAT+: Beyond Wegovy and Ozempic: Biotechs vie for piece of red-hot weight loss market with novel strategies
STAT
MAY 1, 2023
This is part of a series about new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity Revolution. For nearly a decade, Novartis aggressively pursued a drug candidate for muscle disorders, testing it on people with chronic inflammation, elderly people with frailty, hip surgery patients, and other groups.
FDA Conditionally Approves First Drug for Nonregenerative Anemia in Cats With Chronic Kidney Disease
Pharmacy Times
MAY 1, 2023
Molidustat oral suspension is also the first approval for cats under the FDA’s expanded conditional approval pathway.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Struggling Biogen paid its 2 CEOs more than $57M last year, including $30.5M to new chief Chris Viehbacher
Fierce Pharma
MAY 1, 2023
Struggling Biogen paid its 2 CEOs more than $57M last year, including $30.
Listen to Patients, Caregivers to Provide Optimal Care in Pediatric Atopic Dermatitis
Pharmacy Times
MAY 1, 2023
Pharmacists play key roles in navigating prior authorizations and other limits on utilization, as well as educating and listening to patients and caregivers.
Astellas Pharma agrees to buy Iveric bio for about $5.9bn
Pharmaceutical Technology
MAY 1, 2023
Astellas Pharma has entered into a definitive agreement to buy US-based biopharmaceutical company Iveric bio, in a deal valued at nearly $5.9bn. Under the deal terms, the company, through Astellas US Holding’s wholly owned subsidiary Berry Merger Sub, will acquire all the outstanding Iveric Bio shares for $40.00 in cash for each share. Both the companies’ Boards of Directors have unanimously approved the deal.
FDA Gives Final Approval to Sodium Oxybate for Cataplexy or Excessive Daytime Sleepiness in Adults With Narcolepsy
Pharmacy Times
MAY 1, 2023
The final approval was based on efficacy and safety data from the phase 3 REST-ON study.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Doctors, influencers call on their peers to use social media to 'pre-bunk' dangerous misinformation
Fierce Healthcare
MAY 1, 2023
Doctors, influencers call on their peers to use social media to 'pre-bunk' dangerous misinformation aburky Mon, 05/01/2023 - 18:49
Improved Communication Helps Mental Health Outcomes for Families of Those With SABI
Pharmacy Times
MAY 1, 2023
Investigators suggest that a checklist completed by physicians and family members of individuals with severe acute brain injury may improve management needs.
Survey: Anti-LGBTQ legislation takes alarming mental-health toll on queer youth
STAT
MAY 1, 2023
Across the U.S., anti-LGBTQ legislation — and especially anti-trans legislation — is limiting queer youth’s access to everything from bathrooms to gender-affirming surgery. A new national survey from the Trevor Project paints a stark picture of the mental-health toll of these forces: LGBTQ youth consider and attempt suicide at alarmingly high rates, and nearly one-third say their mental health was poor “most of the time or always” due to anti-LGBTQ policies and
Publix reports Q1 2023 results
Drug Store News
MAY 1, 2023
Publix’s sales for the three months ended April 1, 2023, were $14.3 billion, an 8.2% increase from $13.2 billion in 2022.
Expansive investigation into Stanford president’s past research will be ‘substantially complete’ by mid-July
STAT
MAY 1, 2023
An investigation by a special committee of Stanford’s board of trustees into alleged scientific misconduct by Marc Tessier-Lavigne , the university’s president and a prominent neuroscientist, has involved “hundreds of hours of meetings and witness interviews” and will be “substantially complete” by mid-July, the panel said Sunday.
So Delicious Dairy Free enters oat milk space
Drug Store News
MAY 1, 2023
So Delicious Organic Oatmilk is crafted with organic oats and ingredients and comes in two flavors.
STAT+: Astellas acquires Iveric Bio for $5.9B, entering competition to treat common cause of vision loss
STAT
MAY 1, 2023
Japanese drugmaker Astellas said late Sunday it would acquire eye drug developer Iveric Bio for $5.9 billion, betting heavily on a prospective treatment for a form of vision loss that affects around 1 million people in the U.S. Iveric had been competing with another biotech, Apellis Pharmaceuticals, to develop the first therapy for geographic atrophy, a disease of aging in which parts of the retina waste away, forming irreversible blind spots.
Teva, MedinCell win FDA approval for slow-release schizophrenia drug Uzedy
Fierce Pharma
MAY 1, 2023
Teva, MedinCell win FDA approval for slow-release schizophrenia drug Uzedy kdunleavy Mon, 05/01/2023 - 07:35
Mental health is a major concern for employers. Here's where they say their health plans can improve
Fierce Healthcare
MAY 1, 2023
Mental health is a major concern for employers.
STAT+: Senators delay start date for possible PBM reforms
STAT
MAY 1, 2023
WASHINGTON — Pharmacy benefit managers may have gotten themselves a slight reprieve. Senators drafting reforms to the drug middlemen industry have delayed their effective date by at least 10 months, according to new documents obtained by STAT. The original date that pharmacy benefit manager reforms were supposed to take effect was Jan. 1, 2025.
What do the results of your anxiety screening mean?
The Checkup by Singlecare
MAY 1, 2023
If you’ve been feeling more anxious than usual, it can be hard to tell if those feelings are a reasonable response to something stressful or worrying in your life or a sign that you have generalized anxiety disorder (GAD). Many people dismiss feelings of anxiety as temporary, or something they just need to “get over,” when in reality, they are struggling with a common—and, typically, treatable—mental health condition.
In a small new study, scientists working on an AI ‘brain decoder’ inch closer than ever to reading minds
STAT
MAY 1, 2023
Alexander Huth settled into an MRI machine in the Austin, Texas, neuroscience research building where he worked, a cozy blanket draped over him to stave off the chill from the machine’s magnet, and soundproof earbuds to drown out its drone. The sound in the earbuds, though, came through loud and clear. “From the New York Times and WBUR Boston, this is ‘Modern Love,’” the podcast began.
Revlon emerges from bankruptcy with board led by former Sephora, Walgreens Boots Alliance executives
Drug Store News
MAY 1, 2023
Revlon is looking to emerge from bankruptcy by forming a new board of directors with senior executives of such brands as Sephora, Bloomin’ and Walgreens Boots Alliance
Nearly a third of nurses looking for the exit, survey shows. Here's what health systems can do to reverse the trend
Fierce Healthcare
MAY 1, 2023
Nearly a third of nurses looking for the exit, survey shows.
Giant's dietitians kick off virtual workshops in May
Drug Store News
MAY 1, 2023
Giant’s dietitians are shining a light on the importance of women’s health through a series of interactive workshops.
Let's personalize your content